Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Indian Journal of Dermatology, Venereology and Leprology is Scopus-indexed (Q2, CiteScore 2.5), WoS SCIE. Published by Scientific Scholar.
Checked against the index lists dated .
ISSN 0378-6323Verify ISSN ↗0973-3922Verify ISSN ↗
Publisher: Scientific Scholar
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Dermatology | 72 / 152 | 52nd | Q2 |
| Infectious Diseases | 221 / 361 | 38th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present (also 1985–1995, 1976–1982), best quartile Q2, CiteScore 2.5.
Indian Journal of Dermatology, Venereology and Leprology is Q2 in Dermatology (rank 72 of 152) and Q3 in Infectious Diseases (rank 221 of 361), by CiteScore 2025.
Indian Journal of Dermatology, Venereology and Leprology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.5, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.418, quartile Q3, with an H-index of 67.
Indian Journal of Dermatology, Venereology and Leprology is published by Scientific Scholar. Its print ISSN is 0378-6323 and its online ISSN is 0973-3922.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Indian Journal of Dermatology, Venereology and Leprology has an h-index of 82 and a 2-year mean of 0.91 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q2. On 2-year citations it ranks #83 of 144 Scopus journals in Dermatology.
Indian Journal of Dermatology, Venereology and Leprology published 297 papers in 2025; its busiest recent year was 2021 with 358. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from India (62%), China (12%) and Türkiye (3.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 8 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.